ScienceDex / Researcher record
Gentry, W Brooks
- Intervexion Therapeutics, LLC (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 1% Funded
- Rising Star
- Sustained Excellence
- Program Leader
- Long-Funded
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2001 | $175,500 | 1 | #22,525 |
| 2002 | $175,500 | 1 | #24,410 |
| 2009 | $1,194,659 | 1 | #6,429 |
| 2010 | $2,769,478 | 1 | #2,185 |
| 2014 | $1,287,478 | 1 | #4,978 |
| 2015 | $1,594,873 | 1 | #3,809 |
| 2016 | $2,085,133 | 1 | #2,576 |
| 2017 | $4,796,717 | 2 | #539 |
| 2018 | $2,735,856 | 1 | #1,649 |
| 2019 | $2,368,200 | 2 | #2,406 |
| 2021 | $11,513,394 | 3 | #186 |
| 2022 | $6,433,711 | 2 | #487 |
| 2023 | $4,609,902 | 1 | #852 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20011 record
- FY20021 record
- FY20091 record
- FY20101 record
- FY20141 record
- FY20151 record
- FY20161 record
- FY20172 records
- FY20181 record
- FY20192 records
- FY2021 · selected3 records
- FY20222 records
- FY20231 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Gentry, W Brooks as a PI. Multi-PI records show the full award amount for context.
- 1U01DA055481-01U01Contact PIOUTLAST - A First Multiple-Dose Efficacy Study of IXT-m200, an anti-METH Monoclonal Antibody, in Patients with METH Use Disorder$4.6Maward amount
- 5U01DA053043-02U01Contact PIMeth-OD: A PHASE 2A STUDY OF IXT-M200 IN METHAMPHETAMINE OVERDOSE PATIENTS$3.8Maward amount
- 5U01DA051078-02U01Contact PIOptimization and testing of anti-methamphetamine antibody therapy to support pivotal clinical trials and commercialization$3.2Maward amount
Award organization
Organizations that administered FY2021 awards listing Gentry, W Brooks as a PI.
FY2021 award administered by Intervexion Therapeutics, LLC (AR).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardIntervexion Therapeutics, LLC
- 2009$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2009Entered Top 50% NationallyRanked #6429
- 2010$2M Cumulative Funding
- 2010Entered Top 25% NationallyRanked #2185
- 2014$5M Cumulative Funding
- 2016Program/Center Grant Leader
- 2017$10M Cumulative Funding
- 2017Entered Top 10% NationallyRanked #539
- 2017Entered Top 5% NationallyRanked #539
- 2021$25M Cumulative Funding
- 2021Entered Top 1% NationallyRanked #186